Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, actively working to remove obstacles to innovation.
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...
Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
According to a Wall Street Journal report, the company Preventive is working toward genetically engineering its first baby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback